447 related articles for article (PubMed ID: 24108460)
1. How I treat monoclonal gammopathy of renal significance (MGRS).
Fermand JP; Bridoux F; Kyle RA; Kastritis E; Weiss BM; Cook MA; Drayson MT; Dispenzieri A; Leung N;
Blood; 2013 Nov; 122(22):3583-90. PubMed ID: 24108460
[TBL] [Abstract][Full Text] [Related]
2. [Classification and therapeutic management of monoclonal gammopathies of renal significance].
Javaugue V; Bouteau I; Sirac C; Quellard N; Diolez J; Colombo A; Desport E; Ecotière L; Goujon JM; Fermand JP; Touchard G; Jaccard A; Bridoux F
Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684
[TBL] [Abstract][Full Text] [Related]
3. Dysproteinemias and Glomerular Disease.
Leung N; Drosou ME; Nasr SH
Clin J Am Soc Nephrol; 2018 Jan; 13(1):128-139. PubMed ID: 29114004
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
[TBL] [Abstract][Full Text] [Related]
5. Kidney Histopathologic Spectrum and Clinical Indicators Associated with MGRS.
Yong ZH; Yu XJ; Liu JX; Zhou FD; Wang SX; Zhao MH
Clin J Am Soc Nephrol; 2022 Apr; 17(4):527-534. PubMed ID: 35210280
[TBL] [Abstract][Full Text] [Related]
6. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
7. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
8. Renal pathologic spectrum and clinical outcome of monoclonal gammopathy of renal significance: A large retrospective case series study from a single institute in China.
Yu XJ; Zhang X; Li DY; Wang SX; Zhou FD; Zhao MH
Nephrology (Carlton); 2020 Mar; 25(3):202-211. PubMed ID: 31301197
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal gammapathy of renal significance (MGRS) at the current state: terminology, diagnosis and treatment].
Lysenko Kozlovskaya LV; Rameev VV; Androsova TV
Ter Arkh; 2020 Jul; 92(6):15-22. PubMed ID: 33346488
[TBL] [Abstract][Full Text] [Related]
11. Three cases of monoclonal gammopathy of renal significance after kidney transplantation. De novo C3 glomerulopathy.
Serra N; Facundo C; Canal C; Arce Y; Ayasreh N; Vila A; Bardají B; Silva I; López V; Benito S; Ballarín J; Guirado L
Nefrologia (Engl Ed); 2019; 39(2):198-201. PubMed ID: 29914760
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal gammopathies of renal significance.
Gnanasampanthan S; Kousios A
Clin Med (Lond); 2023 May; 23(3):250-253. PubMed ID: 37236803
[TBL] [Abstract][Full Text] [Related]
13. Nephrotic syndrome secondary to amyloidosis in a patient with monoclonal gammopathy with renal significance (MGRS).
Niculae A; Peride I; Vinereanu V; Rădulescu D; Bratu OG; Geavlete BF; ChecheriŢă IA
Rom J Morphol Embryol; 2017; 58(3):1065-1068. PubMed ID: 29250691
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological and clinical characteristics and outcome of monoclonal gammopathy of renal significance-related lesions in Latin America.
Peña C; Schutz NP; Riva E; Valjalo R; Majlis A; López-Vidal H; Lois V; Zamora D; Ochoa P; Shanley C; Gonzalez JT; Fantl D; Correa G; Ramirez J; Mur P; Silva G; Verri V; Rojas C; Escobar K; Glavic G; Méndez GP;
Nephrology (Carlton); 2020 Jun; 25(6):442-449. PubMed ID: 31825549
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
Sethi S; Fervenza FC; Rajkumar SV
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
[TBL] [Abstract][Full Text] [Related]
16. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
[TBL] [Abstract][Full Text] [Related]
17. The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.
Sethi S; Rajkumar SV; D'Agati VD
J Am Soc Nephrol; 2018 Jul; 29(7):1810-1823. PubMed ID: 29703839
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal gammopathy: The good, the bad and the ugly.
Glavey SV; Leung N
Blood Rev; 2016 May; 30(3):223-31. PubMed ID: 26732417
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
[TBL] [Abstract][Full Text] [Related]
20. Laboratory testing in monoclonal gammopathy of renal significance (MGRS).
Leung N; Barnidge DR; Hutchison CA
Clin Chem Lab Med; 2016 Jun; 54(6):929-37. PubMed ID: 27107835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
